Navigating Hormone Therapy Choices After OophorectomyFor women carrying BRCA1 or BRCA2 pathogenic variants, the decision to ...

Advances in genomic testing are helping doctors identify which tumours truly need chemotherapy — and which patients may do ...

Talazoparib plus enzalutamide reduces progression risk by 50% in men with DNA repair alter ...

Prostate cancer kills more than 10,000 men in England each year. For decades, urologists across the country have been ...

Gynecologic oncology encompasses a biologically heterogeneous group of malignancies that continue to represent a major cause of cancer-related morbidity and ...

ORR in gynecologic cancers with 52.9% in ovarian and 66.7% in USC at 12 weeks by best response per RECIST 1.1 within the therapeutic dose ...

Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment ...

The UK's National Screening Committee has concluded its review of prostate cancer screening in the UK, saying that the harms of a large-scale, national programme would outweigh the benefits. The ...

The alternative text for this image may have been generated using AI. GSK-3β sets Snail's pace. Schlessinger, K. & Hall, A. Nature Cell Biology October (2004) A News and Views article discussing ...

Chemotherapy drugs like doxorubicin and etoposide work by snapping a cancer cell’s DNA in two. The breaks are supposed to be lethal. But in tumors that overexpress the oncoprotein MYC, and that ...

An AI model trained on over 30,000 tumors from 10 different solid cancer types aims to turn complex mutation information into ...

Pancreatic cancer remains the third-leading cause of cancer-related deaths in the United States, after lung and colon cancers. The five-year survival rate holds at just 13%. Some estimates put the ...